相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
HIF-2α regulates CD44 to promote cancer stem cell activation in triple-negative breast cancer via PI3K/AKT/mTOR signaling
Jie Bai et al.
WORLD JOURNAL OF STEM CELLS (2020)
Inhibitory Effects of Tangeretin, a Citrus Peel-Derived Flavonoid, on Breast Cancer Stem Cell Formation through Suppression of Stat3 Signaling
Yu-Chan Ko et al.
MOLECULES (2020)
Downregulation of STAT3, β-Catenin, and Notch-1 by Single and Combinations of siRNA Treatment Enhance Chemosensitivity of Wild Type and Doxorubicin Resistant MCF7 Breast Cancer Cells to Doxorubicin
Walhan Alshaer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Prognostic significance of CD24 and CD44 in breast cancer: a meta-analysis
Zhu Wang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2017)
Expression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancer
An Na Seo et al.
BRITISH JOURNAL OF CANCER (2016)
The Hedgehog signaling pathway is associated with poor prognosis in breast cancer patients with the CD44+/CD24- phenotype
Haishan Zhao et al.
MOLECULAR MEDICINE REPORTS (2016)
Cancer stem cells: a potential target for cancer therapy
Hong Qiu et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
CD44/CD24 as potential prognostic markers in node-positive invasive ductal breast cancer patients treated with adjuvant chemotherapy
Agnieszka Adamczyk et al.
JOURNAL OF MOLECULAR HISTOLOGY (2014)
Expression of cancer stem cell markers in basal and penta-negative breast carcinomas - A study of a series of triple-negative tumors
Diego de Mendonca Uchoa et al.
PATHOLOGY RESEARCH AND PRACTICE (2014)
Clinical relevance of cancer stem cells in bone marrow of early breast cancer patients
A. Giordano et al.
ANNALS OF ONCOLOGY (2013)
Clinical-pathologic significance of cancer stem cell marker expression in familial breast cancers
Anita Bane et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry
Shiwu Wu et al.
BMC CANCER (2012)
A CD44-/CD24+ phenotype is a poor prognostic marker in early invasive breast cancer
Mohamed A. H. Ahmed et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer
Julia Y. S. Tsang et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma
Juanjuan Shan et al.
HEPATOLOGY (2012)
CD44+/CD24- phenotype contributes to malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinoma
Yan Lin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
Immunohistochemical Detection of Breast Cancer Stem Cells in Hormone Receptor-Positive Breast Cancer and Their Role in Response to Endocrine Therapy and Clinical Outcome
Kenji Hashimoto et al.
ONCOLOGY (2012)
An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer
H. E. Lee et al.
BRITISH JOURNAL OF CANCER (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44+CD24lo cancer stem cell phenotype
James M. Reuben et al.
EUROPEAN JOURNAL OF CANCER (2011)
Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype
Sara Ricardo et al.
JOURNAL OF CLINICAL PATHOLOGY (2011)
The CD44+/CD24-phenotype relates to 'triple-negative' state and unfavorable prognosis in breast cancer patients
Alexandra Giatromanolaki et al.
MEDICAL ONCOLOGY (2011)
Impact of CD44+CD24- cells on non-sentinel axillary lymph node metastases in sentinel node-positive breast cancer
Hiroko Nogi et al.
ONCOLOGY REPORTS (2011)
Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance
H. Raza Ali et al.
BREAST CANCER RESEARCH (2011)
The prognostic role of cancer stem cells in breast cancer: a meta-analysis of published literatures
Liheng Zhou et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Reduction of CD44+/CD24- breast cancer cells by conventional cytotoxic chemotherapy
Sebastian Aulmann et al.
HUMAN PATHOLOGY (2010)
The clinicopathologic and prognostic significance of CD44+/CD24-/low and CD44-/CD24+ tumor cells in invasive breast carcinomas
Eleni Mylona et al.
HUMAN PATHOLOGY (2008)
Estrogen-mediated downregulation of CD24 in breast cancer cells
Benny Abraham Kaipparettu et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
The CD44(+)/CD24(-) phenotype is enriched in basal-like breast tumors
Gabriella Honeth et al.
BREAST CANCER RESEARCH (2008)
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney et al.
TRIALS (2007)
CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer
W Hilbe et al.
JOURNAL OF CLINICAL PATHOLOGY (2004)
Stem cells in normal breast development and breast cancer
G Dontu et al.
CELL PROLIFERATION (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
分享论文
